Pace® Life Sciences Completes Successful EMA GMP Inspection at New Jersey Facility
Inspection outcome supports renewal of GMP certificate at Lebanon site providing pharmaceutical analytical testing and development support. MINNEAPOLIS, MINNESOTA /
Life Sciences
Pace® appoints Andy Fenny as President of Pace® Life Sciences to drive strategic growth
Accomplished life sciences executive brings more than 20 years’ experience of CDMO and pharmaceutical leadership to guide Life Sciences division
Pace® Life Sciences Announces Compliant US FDA Inspection of Operations in Research Triangle Park, NC
Proven track record of consistent high quality confirmed at Pace® Life Sciences MINNEAPOLIS, MN: July 23, 2026 – Pace® Life
Pace® Life Sciences to Host Free Virtual Webinar on Evaluating Complete Packaging Systems Under USP <382>
Expert led session designed to help life sciences professionals navigate the evolving expectations for packaging and delivery system evaluation under
Pace® Life Sciences to Lead Targeted Drug Delivery Roundtable at Oligo & Peptides HubXchange
Peter Abbink, PhD, a Pace® Life Sciences expert, will serve as roundtable facilitator for the “Strategies for Targeted Drug Delivery”
Pace® Life Sciences To Deliver Two Speaker Sessions at Society of Quality Assurance (SQA) Annual Meeting 2026
Pace® leadership explores inspection-ready quality systems and quality oversight in outsourced environments MINNEAPOLIS, MN – April 8, 2026 Pace® Life
New Microbial Testing Lab Expansion at Pace® Life Sciences
Expanded microbial limits testing lab in Lebanon, NJ boosts capacity and strengthens analytical services MINNEAPOLIS, MN – April 2, 2026
Pace® Life Sciences to Host Free Webinar on EU Endocrine Disruptor Classification and New CLP Hazard Classes
Toxicologist and Pace® Regulatory Expert Sherry Sachdeva to discuss industry updates & impacts MINNEAPOLIS, MN – March 10, 2026 The European Union has expanded how
Pace® Life Sciences to Host Free Virtual Webinar on Quality Oversight in Fully Outsourced Pharma Operations
Senior Expert, Dr. Julie Barnhill, to share practical strategies for ensuring GxP compliance in virtual and hybrid pharma companies MINNEAPOLIS,
Frank Tagliaferri, Ph.D. Featured in Panel Session on Advancing Oral Drug Delivery Beyond Lipinski’s Rule of 5
Chief Scientific Officer of Pace® Life Sciences Joins Industry Leaders at Advancing Drug Development Forum (ADDF) to Collaborate on Technologies